Cell Suspensions.--Suspeusious from thymus, spleen, and lymph nodes (pooled from inguinal, axillary, brachial, and submandibular nodes) were prepared by teasing in a small amount of medium. Hepes-buffered medium RPMI-1640 (Grand Island Biological Co., Grand island, N. Y.) with 1% antibiotic-antimycotic mixture (Gibco) and 7% pooled heatinactivated human serum was employed (9) . Debris was removed by sedimentation, and the cells were washed twice and resuspended in medium. Erythrocytes in spleen suspensions were lysed with ammonium-chloride solution (10) . All suspensions were passed through no. 27 gauge needles, examined for viability via trypan blue exclusion, and adjusted to the desired concentration of viable cells.
MLR.--Stimulating cells consisted of CBA spleen cells for the allogeneic reaction and syngeneic cells for controls. 15 X 10 e viable stimulating eells/ml were incubated in a 50 #g/ml solution of mitomycin-C for 20 min at 37°C in a water bath, followed by three washes in medium. The MLR itself was carded out in titer plates (220/24A Disco "U" plates, Scientific Educational Products Corp., New York). 0.1 ml of stimulating and 0.1 ml of responding cell suspensions were placed in each cup and the plates sealed with clear mylar covers (35PSM, Linbro Chemical Co., New Haven, Conn.). After 48 h at 37°C, 3/~Ci [aHH]thymidine (Schwarz/ Mann Div., Becton, Dickinson & Co. sp act 1.9 mCi/mmol) in 0.1-ml serum-free medium was added to each cup and incubation continued for another 16 h. The reaction was stopped by chilling to 4°C, the mixtures transferred to centrifuge tubes, washed twice in 50/0 trichloracetic acid, once in methanol, and transferred to counting vials. After evaporation of methanol, 10 ml of scintillation liquid (5 g 2,5-diphenyloxazole and 100 mg 1,4-bis[2-(5-phenyloxazolyl)]-benzene/liter of toluene containing 3% "solubilizer" [Nuclear-Chicago Corp., Des Plaines, Ill.l) was added. The vials were allowed to stand for 12 h and the [SH]thymidine uptake was measured in a Beckman model LS-25 liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif.). Control values from syngeneic combinations were subtracted from the experimental (allogeneic) values. All tests were done in quadruplicate and means and standard errors computed. Statistical comparisonswere done via Student's t test. When the "expected" was compared with the observed value, the SE of the observed value was assumed also for the expected one: this introduced a slight conservative bias in the probability values.
In Vitro Treatment with Anti-O Serum and Complements--Anti-O serum was produced by
injections of AKR mice with CBA thymocytes (10) . The activity could be completely absorbed with mouse brain. For in vitro treatment, 25 X 106 living LN cells/ml were incubated in 0.4 ml of anti-0 serum or in normal AKR serum for 30 rain at 37°C, then for 30 rain at 37°C with 0.6 rul of complement added. The serum of New Zealand rabbits previously screened for low natural toxicity for mouse thymus and spleen cells and also preabsorbed at 4°C ,with lymphoid cells was employed as the complement source (11) .
A TS.--ATS was prepared by immunizing young adult New Zealand white rabbits with C57BL/6J (B6) thymocytes according to Levey and Medawar (12) . It was inactivated at 56°C for 30 rain and absorbed with 1/20th vol of washed B6 erythrocytes.
Irradiation.--Exposure of mice to 1,200 R whole body irradiation was done with a Picker Vanguard machine (Picker Corp., Cleveland, Ohio) under conditions of 280 kV, 20 mA, halfvalue layer 1.28 mm copper, at a distance of 52 cm and an administered dose rate of 137 R/rain. Table I ). lymphoid cells from control animals treated with normal rabbit serum (NRS). Both doses of ATS decreased the reactivity of LN cells by 30-50 % (Figs. 2  and 3 ), whereas the reactivity of spleen cells was decreased only by the higher dose. A paradoxical effect on thymus cells of animals treated with the highest ATS dose was observed. The reactivity increased two to three-fold. This observation of a reciprocal effect on thymocytes and spleen cells parallels Cantor's and Asofsky's findings on the effect of ATS on the GVH reaction of cells derived from these sources (13) .
RESULTS

MLR Standard Curves for Thymus
The Effect of Prior Treatment with A TS on the Capacity of LN Cells, Spleen Cells, and Thymocytes to React in MLR--Lymphoid
LN cells obtained from mice pretreated with 0.075, 0.25, and 0.75 ml ATS showed much less [3H]thymidine uptake in combination with normal thymocytes than did LN cells from NRS-treated animals, i.e., ATS decreased or abolished the ability of LN cells to synergize with thymocytes (Fig. 4) . Fig. 2 the animals were treated with 0.075 ml NRS or ATS 3 days before the test, in Fig. 3 with 0.75 ml. At the higher dose ATS exerted a depressing effect upon MLR of LN cells and spleen cells; however, at the lower dose only the reactivity of LN cells was depressed. Thymocytes demonstrated a paradoxical pattern. Only the higher ATS dose influenced their reactivity which was increased two-to threefold.
Reactivities of LN and Spleen Cells from
5-mo old were irradiated with 1,200 R. 2 h later 10 of these were injected via the tail vein with 100 X l0 s spleen cells from 5-too old syngeneic males. The MLR of cells from spleen and LN of both irradiated and irradiated spleen cell-reconstituted groups were measured 20 h after irradiation, and compared to cells from untreated animals. Irradiation essentially abolished the reactivities of both LN and spleen cells. The irradiated reconstituted group regained some reactivity, about 17 % for LN and for spleen cells about 10 % of that of cells from normal animals. Reconstitution thus resulted in populations in both LN and spleen with impaired ability to react in MLR.
LN cells from irradiated but not reconstituted animals possessed little or no capacity to synergize with normal thymocytes (Fig. 5) . The LN cells from Jr- 
Fro. 5. MLR of 4:1 mixtures of normal thymocytes with normal LN cells or normal Spl cells, or with LN cells derived from irradiated animals (LN-R), or with LN or Spl cells from irradiated and Spl cell-reconstituted mice (LN-RS and Spl-RS).
The hatched columns represent the expected values. In irradiated animals the reconstituting Spl cells migrated partially to lymph nodes and partially to spleens. However, only those which migrated to the LN were able to react synergistically with thymocytes. All animals in this experiment were (B6 X 129)F1 hybrids. radiated spleen cell-reconstituted mice did synergize with thymocytes. By contrast, while normal spleen cells participated well in synergy, the spleen cells from irradiated spleen cell-reconstituted mice clearly did not synergize when mixed with normal thymocytes. Hence, irradiation and reconstitution with spleen cells resulted in two lymphoid populations (in LN and spleen), neither of which reacted well by itself in the MLR, and only one of which (from LN) showed good synergistic activity in combination with thymocytes (Fig. 5) .
Reactivities of Mixtures of Normal Spleen and LN Cells, and of Spleen and LN Cells from Irradiated Animals with and without Reconstitution by Spleen
Cells.--The response of a normal spleen-LN-cell mixture was significantly elevated compared to expected values, demonstrating synergy among these cell populations (Fig. 6) . Mixtures of spleen and LN cells from irradiated animals were nonreactive; however, mixtures from irradiated spleen cell-reconstituted animals showed some evidence of synergy, although the total response was only 16 to 28 % of that of normal spleen cells. These results were obtained with cells from (B6 X 129)F1 hybrid mice. A mixture of normal spleen and LN cells from B6 mice did not manifest synergy, even though (Fig. 1) thymus and LN cells of this strain do synergize.
DISCUSSION
Our results confirm and extend prior observations that two thymus-dependent cell populations interact synergistically in the MLR (6, 8) . The interaction can be demonstrated at various ratios of total responding to constant stimulator cell numbers (Fig. 1) , also when the total number of responding cells is held constant but the ratio of the T-cell subpopulations allowed to vary (8) , or when the concentrations per ml of both responding and stimulating cells are allowed to increase (8) . Synergy in the MLR is clearly analogous to that described by Cantor and Asofsky and coworkers (1, 2, 5) using the GVH reaction as an indicator system. They described so-called precursor T1 cells in the thymus and spleen of Balb/C mice. The GVH reactivity attributed to these T1 cells could be increased by interaction with so-called amplifier or T2 cells from peripheral blood .or lymph nodes. It is pertinent to state in what ways the synergy we observed in MLR is similar to that described for the GVH reaction, and whether any apparent differences exist.
Similarities may first be emphasized. Our experiment using combinations of thymocytes and LN cells in which either one of the populations consisted of F1 hybrid cells derived from mice of the B6-responding strain and the CBA-stimulating strain indicated that in the MLR model (8) , just as in the GVH model (1), both responding populations must be allogeneic to the stimulating cells to participate in synergy. Also, synergy was not observed if either responding cell population was inactivated, via freezing and thawing by Cantor et al. (14) , or in our experiments by pretreatment with mitomycin-C.
Cantor (4) demonstrated that both amplifier (T2) and precursor (T1) cells involved in synergy in the GVH reaction were 0 (q-) cells, and that normal LN cells contained both types of cells, although T~ >> T1. The amplifier activity of the LN cells was slightly less susceptible to low doses of anti-0 serum than was the overall GVH reactivity. In our MLR experiments we noted that treatment of LN cells with increasing concentrations of anti-0 resulted in loss of both MLR responding and synergizing activities concurrently (Table I) . Since different mouse strains and test situations were being employed, we do not regard this lack of a differential effect of anti-0 serum in MLR as necessarily a significant difference.
In the GVH model the spleen appeared to contain both T1 and T2 cells (T1 >> T2), and these showed different migratory patterns when injected into lethally irradiated mice (5). T1 cells preferably went to the spleens of the irradiated mice and T2 cells into the recirculating lymphocyte pool, which included the lymph nodes. Thus, the spleen cells from lethally irradiated spleen cell-reconstituted mice should represent a pure Tl-cell population and LN cells a pure T~-cell population. Therefore, the LN cells but not the spleen cells of reconstituted mice should synergize with normal thymocytes. This was exactly what we obtained in our MLR model, as shown in Fig. 5 . Spleen cells of normal mice of the appropriate strain synergize with thymocytes. Thus, the spleen contains two subpopulations active in both GVH reaction and MLR and these demonstrate similar migratory patterns upon injection into irradiated recipients. The parallel here between GVH and MLR results was not however absolute. In the GVH reaction the combination of spleen and LN cells in a ratio of 5:1 from irradiated reconstituted mice gave reactivity comparable to normal spleen cells. In MLR, while reactivity could be demonstrated under these conditions, it was substantially less than that of normal spleen cells.
The major lesion produced by moderate doses of ATS involves the recirculating lymphocytes (15, 16) . Itinerant-recirculating spleen lymphocytes (T2 cell) and residual sessile cells (T1 cell), which latter are relatively resistant to ATS, participate in the GVH response (2). We found almost no loss of spleen cell reactivity in MLR after treatment with a low dose of ATS, while LN-cell reactivities were markedly decreased (Fig. 2) . By contrast, a higher dose of ATS affected both tissues (Fig. 3) . Thus, in the MLR two cell types can react, one derived from lymph nodes, which recirculates and is relatively sensitive to ATS, and a second or sessile type from spleens. A paradoxical effect of ATS on thymocytes was observed only when the higher doses of ATS (0.75 ml) was used.
We could not demonstrate a differential effect of ATS or of anti-0 serum upon the mixed lymphocyte reactivity and synergizing capability of LN cells, although this had been shown in the GVH reaction by Cantor and Asofsky (2, 4).
Other possible differences between GVH and MLR models can be mentioned. While in the GVH reaction a clear relationship exists between the response as measured in the Simonsen assay and the logarithms of the cell doses in the range 0.5-20 X 10 ~ cells/mouse (14) , we observed in the range of 1-8 X 106 cells/ml in MLR a more or less linear relationship between [aH]thymidine uptake and numbers of responding cells. Above a certain cell concentration (about 12 × 106 cells/ml), no further increase could be obtained under the conditions of our test. Differences in reaction times are also evident when the GVH reaction and MLR are compared. A measurable response in MLR is achieved by the 2nd day, while the GVH reaction usually requires a longer time (9 days in the experiments by Cantor and Asofsky).
The GVH reaction is of course a far more complicated event (17) than the MLR. In the GVH reaction the recognition of antigen by certain lymphocytes is followed by an inflammatory response by the host, by the transformation of reacting donor lymphocytes into proliferating blasts, and by damage to host cells. The MLC reaction is considered to be an in vitro model of merely the recognition or first phase of the GVH reaction (18) . Comparing the complexity of events involved respectively in the GVH reaction and MLR, it is not surprising that some apparent differences might be found in the behavior of the thymus-dependent subpopulations responsible for both reactions. However, the similarities are sufficient to suggest that identical subpopulations may be involved.
In a recent study using the cell-mediated lymphocytotoxic reaction against target cells, Wagner (7) noted synergy between thymocytes and peripheral T cells, thus extending an earlier report by Cohen and Howe (6). Wagner found, however, that for cell-mediated cytotoxicity the thymus cells manifested mainly a helper (amplifying) activity, and that peripheral T cells provided the major source for the precursor ceils of cytotoxic lymphocytes. This is in fact opposite to the roles assigned for T1-T2-cell interaction in the GVH reaction. One notes that in the mouse the MLR is directed against so-called lymphocyte-defined (LD) antigens, or against LD plus serologically defined (SD) antigens, and the cytotoxic reaction only against SD antigens (7). Our own studies do not bear directly upon the question of which T-cell subpopulation is precursor, which amplifies, but do indicate that all the described parameters of synergy itself may be manifested during the recognition phase of the cellular immune reaction. SUMMARY
The present studies have shown that two subpopulations of thymus-dependent lymphocytes may act synergistically in the mixed lymphocyte reaction (MLR) in the mouse. One subpopulation was well represented in the young adult thymus and the other in lymph nodes. For optimum synergy, both populations must be allogeneic to the stimulator cells. Pretreatment of either population with mitomycin-C abolished synergy. Anti-O serum abolished both MLR responding and synergizing activities of lymphoid cells. The two thymusdependent subpopulations were both present in the spleen, and displayed different migratory patterns when injected into irradiated mice: one population went to spleens of the irradiated mice, the other to lymph nodes. The effects of antithymocyte serum on the MLR and upon synergy were assessed. While minor differences exist and are herein described, our overall results strongly suggest that in our experiments with synergy in MLR, we may be dealing with the same T1-and T2-cell subpopulations described by Cantor and Asofsky and coworkers (1, 2, 4, 5, 14) as displaying synergy in the graft-vs.-host reaction.
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